Several clinical investigations on the course and outcome of pregnanci
es following cordocentesis have mentioned the occurrence of fetal brad
ycardia at the time of umbilical cord puncture. The prognostic impact
of this common complication has remained controversial. Our purpose wa
s to investigate the prevalence and the short-term and long-term conse
quences of fetal bradycardia associated with cordocentesis. This study
included all 339 cordocenteses performed in 290 fetuses at the Divisi
on of Prenatal Diagnosis and Therapy, University of Vienna, between 19
91 and 1994. Clinically significant bradycardia was defined as a drop
in the heart rate to less than 100 beats/min for a period of greater t
han or equal to 60 s. Bradycardia during or immediately after cordocen
tesis was observed in 13 cases (3.8 per cent). The fetal/neonatal loss
rate per procedure was 61.5 per cent (8/13) in cases with bradycardia
and 3.1 per cent (10/326) in those without bradycardia (P < 0.001). E
arly gestational age and hydrops fetalis correlated significantly with
the development of bradycardia at cordocentesis. The other risk group
s, including fetuses with intrauterine growth retardation, the punctur
e site, and the number of puncture attempts did not correlate with fet
al bradycardia. Our results indicate that prolonged fetal bradycardia
during or after cordocentesis is characteristic of a group of fetuses
with an especially unfavourable prognosis. (C) 1997 by John Wiley & So
ns, Ltd.